MedPath

An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men

Phase 3
Withdrawn
Conditions
Hypogonadism
Testosterone Deficiency
Interventions
Drug: ABT-SLV176
Registration Number
NCT02082197
Lead Sponsor
AbbVie
Brief Summary

This is an open-study with a 26 week open label treatment period followed by an optional 26 week open label extension. The total treatment period will be 52 weeks.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

Low testosterone

Exclusion Criteria
  • Normal testosterone levels
  • Elevated Prostatic Specific Antigen (PSA)
  • History of breast or prostate cancer

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ABT-SLV176ABT-SLV176ABT-SLV176 administered daily
Primary Outcome Measures
NameTimeMethod
Percentage of subjects with serum total testosterone average concentration, Cavg(0-24)At Week 12

Cavg (0-24) is the time-averaged Concentration Over the Dosing Interval of 24 Hours.

Secondary Outcome Measures
NameTimeMethod
Percentage of subjects falling within the pre-defined ranges of maximum total testosterone concentration (Cmax)At Week 2, Week 4, Week 12 and Week 52

Cmax is the maximum concentration.

Average serum total testosterone and Dihydrotestosterone (DHT) concentration (Cavg)At Week 2, Week 4, Week 12 and Week 52

Cavg is the average concentration.

Trial Locations

Locations (42)

Site Reference ID/Investigator# 124395

🇺🇸

Wichita, Kansas, United States

Site Reference ID/Investigator# 125782

🇺🇸

Mesa, Arizona, United States

Site Reference ID/Investigator# 123948

🇺🇸

Anaheim, California, United States

Site Reference ID/Investigator# 123930

🇺🇸

Dunwoody, Georgia, United States

Site Reference ID/Investigator# 124157

🇺🇸

Phoenix, Arizona, United States

Site Reference ID/Investigator# 124160

🇺🇸

Las Vegas, Nevada, United States

Site Reference ID/Investigator# 123925

🇺🇸

Baltimore, Maryland, United States

Site Reference ID/Investigator# 123939

🇺🇸

Las Vegas, Nevada, United States

Site Reference ID/Investigator# 123944

🇺🇸

San Antonio, Texas, United States

Site Reference ID/Investigator# 123895

🇺🇸

Chattanooga, Tennessee, United States

Site Reference ID/Investigator# 123946

🇺🇸

Nashville, Tennessee, United States

Site Reference ID/Investigator# 123929

🇺🇸

Jacksonville, Florida, United States

Site Reference ID/Investigator# 125784

🇺🇸

Crestview Hills, Kentucky, United States

Site Reference ID/Investigator# 124164

🇺🇸

Los Angeles, California, United States

Site Reference ID/Investigator# 123928

🇺🇸

Poughkeepsie, New York, United States

Site Reference ID/Investigator# 123938

🇺🇸

Huntsville, Alabama, United States

Site Reference ID/Investigator# 123919

🇺🇸

Lexington, Kentucky, United States

Site Reference ID/Investigator# 123921

🇺🇸

Salisbury, North Carolina, United States

Site Reference ID/Investigator# 123947

🇺🇸

Clearwater, Florida, United States

Site Reference ID/Investigator# 124162

🇺🇸

Cleveland, Ohio, United States

Site Reference ID/Investigator# 124038

🇺🇸

Colorado Springs, Colorado, United States

Site Reference ID/Investigator# 123945

🇺🇸

Ponte Vedra Beach, Florida, United States

Site Reference ID/Investigator# 125783

🇺🇸

New York, New York, United States

Site Reference ID/Investigator# 123931

🇺🇸

Jenkintown, Pennsylvania, United States

Site Reference ID/Investigator# 123943

🇺🇸

Albuquerque, New Mexico, United States

Site Reference ID/Investigator# 123923

🇺🇸

Austin, Texas, United States

Site Reference ID/Investigator# 124167

🇺🇸

Dallas, Texas, United States

Site Reference ID/Investigator# 123926

🇺🇸

Garden City, New York, United States

Site Reference ID/Investigator# 124163

🇺🇸

Birmingham, Alabama, United States

Site Reference ID/Investigator# 126202

🇺🇸

Denver, Colorado, United States

Site Reference ID/Investigator# 123922

🇺🇸

Dallas, Texas, United States

Site Reference ID/Investigator# 123937

🇺🇸

Tucson, Arizona, United States

Site Reference ID/Investigator# 123940

🇺🇸

Ocala, Florida, United States

Site Reference ID/Investigator# 124166

🇺🇸

Orlando, Florida, United States

Site Reference ID/Investigator# 123936

🇺🇸

Methuen, Massachusetts, United States

Site Reference ID/Investigator# 123917

🇺🇸

Bala Cynwyd, Pennsylvania, United States

Site Reference ID/Investigator# 123933

🇺🇸

Morehead City, North Carolina, United States

Site Reference ID/Investigator# 123924

🇺🇸

Greer, South Carolina, United States

Site Reference ID/Investigator# 124165

🇺🇸

Charlotte, North Carolina, United States

Site Reference ID/Investigator# 123932

🇺🇸

Lawrenceville, New Jersey, United States

Site Reference ID/Investigator# 123927

🇺🇸

Middlebury, Connecticut, United States

Site Reference ID/Investigator# 123920

🇺🇸

Los Gatos, California, United States

© Copyright 2025. All Rights Reserved by MedPath